Middle East and Africa Opioid Drugs Market 2019-2028

MARKET OUTLOOK

The publisher's report on the opioid drugs market in the Middle East and Africa states that the industry will grow with a CAGR of 2.60% in the forecast period 2019-2028. Saudi Arabia, Turkey, South Africa, the UAE, and Rest of MEA together shape the market in this region.
Similar to most developing nations, Turkey has been witnessing an alarming rise in the incidence of cancer and cancer deaths. This rise is attributable to the improvement in the registry system and better access to diagnostic services. Over the last few years, the concept of palliative care has emerged in the country, with the development of pain control units in the majority of the healthcare centers. However, the rate of morphine consumption per capita is low, and the substance is not widely available either. This presents major growth opportunities for opioid drug manufacturers to capitalize on this unexplored market.

In Saudi Arabia, the number of people affected with cancer is rising significantly, and the mortality rate due to the disease is also very high. Most of these cases are detected at the later stages. It thererefore becomes imperative to treat the patients with opioid drugs to alleviate their pain. This has generated demand for these drugs in the country. However, most people in the country, though being extremely concerned about having the condition, lack knowledge about the use of opioids for pain management or are misinformed. This acts as a hurdle in the path of market growth.

COMPETITIVE OUTLOOK

The notable players in this market include Hikma Pharmaceuticals Plc, Daiichi Sankyo, Indivior Inc, Mylan NV, Collegium Pharmaceutical Inc, Johnson Johnson, Cipher Pharmaceuticals Inc, Purdue Pharma LP, and Pfizer Inc.

1. Middle East and Africa Opioid Drugs Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Technological Advancements to Fight Against Opioid Drug Crisis
2.2.2. Different Sources of Procuring Opioids
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Growth in Medical Cases & Rising Prevalence of Cancer
2.6.2. Increase in the Use of Abuse-Deterrent Formulations to Restrict the Rise of Opioid Dependence
2.6.3. Demand for Palliative Therapy
2.7. Market Restraints
2.7.1. Government Rules and Regulations
2.7.2. Increased Number of Lawsuits Against the Manufacturers of Opiod Drugs
2.7.3. Usage of Opioids for Non-Medical Purposes
2.8. Market Opportunities
2.8.1. Rising Commercial Success and Market Share of Opioid Drugs
2.8.2. Growth of Investments in Research of Pharmaceutical Uses of Opioids
2.9. Market Challenges
2.9.1. Opioid Epidemic Spreading
2.9.2. Rising Death Rate Due to Opioid Overdose
2.10. Covid-19 Impact on the Opioid Drugs Market

3. Middle East and Africa Opioid Drugs Market Outlook - by Product

3.1. Buprenorphine
3.2. Fentanyl
3.3. Hydrocodone
3.4. Morphine
3.5. Oxycodone
3.6. Tramadol
3.7. Other Products

4. Middle East and Africa Opioid Drugss Market Outlook - by Application

4.1. Pain Relief
4.1.1. Cancer Pain
4.1.2. Postoperative Pain Management
4.1.3. Lower Back Pain
4.1.4. Orthopedic
4.1.5. Neuropathic
4.1.6. Fibromyalgia
4.2. Anesthesia
4.3. Cough Suppression
4.4. Diarrhea Suppression
4.5. De-Addiction

5. Middle East and Africa Opioid Drugs Market – Regional Outlook

5.1. United Arab Emirates
5.2. Turkey
5.3. Saudi Arabia
5.4. South Africa
5.5. Rest of Middle East and Africa

6. Competitive Landscape

6.1. Acura Pharmaceuticals
6.2. Biodelivery Sciences International Inc
6.3. Cipher Pharmaceuticals Inc
6.4. Allergan (Acquired by Abbvie)
6.5. Collegium Pharmaceutical Inc
6.6. Daiichi Sankyo
6.7. Hikma Pharmaceuticals plc
6.8. Indivior Inc
6.9. Janssen Pharmaceuticals Inc
6.10. Johnson Johnson
6.11. Lannett Co Inc
6.12. Lupin Ltd
6.13. Mylan Nv
6.14. Pfizer Inc
6.15. Purdue Pharma Lp
6.16. Sanofi-Aventis Sa
6.17. Sun Pharmaceutical Industries Ltd
6.18. Teva Pharmaceutical Industries Ltd

7. Methodology & Scope

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

List of Tables:

Table 1: Middle East and Africa Opioid Drugs Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Middle East and Africa Opioid Drugs Market, by Product, 2019-2028 (In $ Million)
Table 4: Middle East and Africa Opioid Drugs Market, by Application, 2019-2028 (In $ Million)
Table 5: Middle East and Africa Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Table 6: Middle East and Africa Opioid Drugs Market, by Country, 2019-2028 (In $ Million)

List of Figures:

Figure 1: Porter's Five Force Analysis
Figure 2: Market Attractiveness Index
Figure 3: Middle East and Africa Opioid Drugs Market, by Buprenorphine, 2019-2028 (In $ Million)
Figure 4: Middle East and Africa Opioid Drugs Market, by Fentanyl, 2019-2028 (In $ Million)
Figure 5: Middle East and Africa Opioid Drugs Market, by Hydrocodone, 2019-2028 (In $ Million)
Figure 6: Middle East and Africa Opioid Drugs Market, by Morphine, 2019-2028 (In $ Million)
Figure 7: Middle East and Africa Opioid Drugs Market, by Oxycodone, 2019-2028 (In $ Million)
Figure 8: Middle East and Africa Opioid Drugs Market, by Tramadol, 2019-2028 (In $ Million)
Figure 9: Middle East and Africa Opioid Drugs Market, by Other Products, 2019-2028 (In $ Million)
Figure 10: Middle East and Africa Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Figure 11: Middle East and Africa Opioid Drugs Market, by Cancer Pain, 2019-2028 (In $ Million)
Figure 12: Middle East and Africa Opioid Drugs Market, by Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 13: Middle East and Africa Opioid Drugs Market, by Lower Back Pain, 2019-2028 (In $ Million)
Figure 14: Middle East and Africa Opioid Drugs Market, by Orthopedic, 2019-2028 (In $ Million)
Figure 15: Middle East and Africa Opioid Drugs Market, by Neuropathic, 2019-2028 (In $ Million)
Figure 16: Middle East and Africa Opioid Drugs Market, by Fibromyalgia, 2019-2028 (In $ Million)
Figure 17: Middle East and Africa Opioid Drugs Market, by Anesthesia 2019-2028, (In $ Million)
Figure 18: Middle East and Africa Opioid Drugs Market, by Cough Suppression, 2019-2028 (In $ Million)
Figure 19: Middle East and Africa Opioid Drugs Market, by Diarrhea Suppression 2019-2028 (In $ Million)
Figure 20: Middle East and Africa Opioid Drugs Market, by De-Addiction, 2019-2028 (In $ Million)
Figure 21: Middle East and Africa Opioid Drugs Market; Regional Outlook 2019 & 2028 (In %)
Figure 22: United Arab Emirates Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 23: Turkey Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 24: Saudi Arabia Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 25: South Africa Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 26: Rest of Middle East & Africa Opioid Drugs Market, 2019-2028 (In $ Million)